Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,102
Total Claims
$1.1M
Drug Cost
289
Beneficiaries
$3,929
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 99 Surgery providers
+1427%
Cost per patient vs peers
$3,929 vs $257 avg
+310%
Brand preference vs peers
19.9% vs 4.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 2,410 claims · $721K
Generic: 9,679 claims · $414K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 731 | $201K |
| Droxidopa | 20 | $98K |
| Linagliptin | 237 | $62K |
| Dolutegravir Sodium | 37 | $39K |
| Deutetrabenazine | 14 | $33K |
| Sacubitril/Valsartan | 89 | $30K |
| Fluticasone/Vilanterol | 92 | $26K |
| Empagliflozin | 83 | $25K |
| Rivaroxaban | 88 | $24K |
| Dextromethorphan Hbr/Quinidine | 27 | $21K |
| Pyridostigmine Bromide | 22 | $19K |
| Linaclotide | 36 | $19K |
| Fluticasone/Umeclidin/Vilanter | 38 | $17K |
| Rilpivirine Hcl | 25 | $17K |
| Sitagliptin Phosphate | 58 | $16K |
Prescribing Profile
Patient Profile
80
Avg Age
65%
Female
3.01
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About